Desthiobiotin (DTB)–modified and TAMRA-modified 2″OMeNAD+ are RNA 2′-phosphotransferase (Tpt1) poisons that enable affinity-tagging and fluorescence-tagging of internal RNA 2′-phosphate groups
- 1Department of Chemistry, University of Konstanz, Konstanz 78457, Germany
- 2Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
- Corresponding authors: shumans{at}mskcc.org; renata.kasprzyk{at}hest.ethz.ch
-
↵3 These authors contributed equally to this work.
-
Handling editor: Eric Phizicky
Abstract
RNA 2′-phosphotransferase Tpt1 catalyzes the removal of an internal RNA 2′-PO4 via a two-step mechanism in which (i) the 2′-PO4 attacks NAD+ C1″ to form an RNA-2′-phospho-(ADP-ribose) intermediate and nicotinamide; and (ii) transesterification of the ADP-ribose O2″ to the RNA 2′-phosphodiester yields 2′-OH RNA and ADP-ribose-1″,2″-cyclic phosphate. We showed previously that 2″OMeNAD+, a synthetic NAD+ analog that cannot support step 2 transesterification, is an effective step 1 substrate for Runella slithyformis Tpt1 (RslTpt1) in a reaction that generates the normally undetectable RNA-2′-phospho-(ADP-ribose) intermediate as an abortive product. Here we report the chemical synthesis of two novel 2″OMeNAD+ compounds, containing desthiobiotin (DTB) linked to adenine C2 or N6 via a diaminohexane linker. Whereas both analogs poison the RslTpt1 reaction after step 1, the 2″OMeNAD-2-DTB derivative supports a higher yield of RNA-2′-phospho-(DTB-ADP-2″OMe-ribose) product, which can be recovered by adsorption to streptavidin beads and elution with biotin. Our results recommend 2″OMeNAD-2-DTB as a novel affinity-tag probe of RNA 2′-phosphate modification. We synthesized a fluorescent derivative, 2″OMeNAD-2-TAMRA, and found that it, too, is an effective step 1 substrate for RslTpt1 that allows fluorescent labeling of an RNA 2′-phosphate.
Keywords
Footnotes
-
Article is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.080707.125.
- Received July 29, 2025.
- Accepted September 3, 2025.
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml). After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.










